Evaxion outlines expanded cash runway into 2H 2027 and anticipates data milestones for EVX-01 and EVX-04
Source: SeekingAlpha
2026-03-06 14:47:02 ET
More on Evaxion Biotech ADS
- Evaxion A/S (EVAX) Q4 2025 Earnings Call Transcript
- Evaxion A/S 2025 Q4 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on Evaxion Biotech ADS
- Historical earnings data for Evaxion Biotech ADS
- Financial information for Evaxion Biotech ADS
Read the full article on Seeking Alpha
For further details see:
Evaxion outlines expanded cash runway into 2H 2027 and anticipates data milestones for EVX-01 and EVX-04
Evaxion Biotech A/S
NASDAQ: EVAX
EVAX Trading
-5.2% G/L:
$3.08 Last:
8,692 Volume:
$3.12 Open:
EVAX Latest News
March 02, 2026 08:00:00 am
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
EVAX Stock Data
$28,519,826
7,782,965
N/A
6
N/A
Biotechnology & Life Sciences
Healthcare
DK
Hoersholm
